Literature DB >> 26310538

Heart rate response to regadenoson: Making the case for its value in clinical practice.

Efstathia Andrikopoulou1,2, Fadi G Hage3,4.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26310538     DOI： 10.1007/s12350-015-0269-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  25 in total

1.  Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms.

Authors:  Rohit Bhatheja; Gary S Francis; Claire E Pothier; Michael S Lauer
Journal:  Am J Cardiol       Date:  2005-05-15       Impact factor: 2.778

2.  Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.

Authors:  Stephanie El-Hajj; Wael A AlJaroudi; Ayman Farag; Steven Bleich; Padma Manaoragada; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-05-28       Impact factor: 5.952

3.  Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging.

Authors:  Shishir Mathur; Anuj R Shah; Alan W Ahlberg; Deborah M Katten; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2010-05-19       Impact factor: 5.952

4.  A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.

Authors:  Fadi G Hage; Phillip Dean; Fahad Iqbal; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-07-22       Impact factor: 5.952

5.  Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study.

Authors:  Aiden Abidov; Rory Hachamovitch; Sean W Hayes; Chee Keong Ng; Ishac Cohen; John D Friedman; Guido Germano; Daniel S Berman
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690

6.  The prognostic value of regadenoson myocardial perfusion imaging.

Authors:  Fadi G Hage; Gopal Ghimire; Davis Lester; Joshua Mckay; Steven Bleich; Stephanie El-Hajj; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2015-02-14       Impact factor: 5.952

7.  Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.

Authors:  Fahad M Iqbal; Wael Al Jaroudi; Kumar Sanam; Aaron Sweeney; Jaekyeong Heo; Ami E Iskandrian; Fadi G Hage
Journal:  Am J Cardiol       Date:  2012-10-27       Impact factor: 2.778

8.  Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.

Authors:  Fadi G Hage; Jaekyeong Heo; Billy Franks; Luiz Belardinelli; Brent Blackburn; Whedy Wang; Ami E Iskandrian
Journal:  Am Heart J       Date:  2009-03-06       Impact factor: 4.749

9.  Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction.

Authors:  Sabha Bhatti; Abdul Hakeem; Sunitha Dhanalakota; Gurunanthan Palani; Zehra Husain; Gordon Jacobsen; Karthik Ananthasubramaniam
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-04-03       Impact factor: 6.875

Review 10.  Anatomy and physiology of coronary blood flow.

Authors:  Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952
View more
  16 in total

1.  Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes.

Authors:  Christopher W Ives; Wael A AlJaroudi; Vineeta Kumar; Ayman Farag; Dana V Rizk; Suzanne Oparil; Ami E Iskandrian; Fadi G Hage
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-07       Impact factor: 9.236

Review 2.  Multi-modality imaging: Bird's eye view from the 2016 American Heart Association Scientific Sessions.

Authors:  Wael A AlJaroudi; Steven G Lloyd; Farooq A Chaudhry; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-02-15       Impact factor: 5.952

3.  Indirect evidence of sympathetic stimulation by regadenoson.

Authors:  G Ross Farris; Fadi G Hage; Vineet Kumar; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2018-06-13       Impact factor: 5.952

Review 4.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2016: Part 2 of 2-myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2017-04-06       Impact factor: 5.952

5.  Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2015-Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2016-02-18       Impact factor: 5.952

6.  The blood pressure response to vasodilator stress does not provide independent prognostic information.

Authors:  Eliana Reyes; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-08-29       Impact factor: 5.952

7.  Risk stratification for renal transplantation: A role for heart rate response?

Authors:  Matthew Topel; Leslee J Shaw; Joe X Xie
Journal:  J Nucl Cardiol       Date:  2017-10-30       Impact factor: 5.952

8.  Myocardial stunning by gated SPECT: An old tool reinvented in a stunning turn.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-14       Impact factor: 5.952

9.  Adverse effects associated with regadenoson myocardial perfusion imaging.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

Review 10.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.